FindMyRecallSubscribe
Class I: serious health riskTerminated

Genentech Activase Recall

Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-…

Genentech, Inc. · South San Francisco, CA

Risk level
Class I
Reported by FDA
Sep 27, 2017
Recall ID
D-1175-2017
Check your lot numberHow we source this data

Summary

Genentech recalled Activase starting Sep 5, 2017. The FDA classified it as Class I (serious health risk) and published enforcement report D-1175-2017 on Sep 27, 2017. Reason: Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials. Status: Terminated.

Why it was recalled

Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.

Product description

Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27

Lot numbers, UPCs & expiration codes

Lot# 3128243, 3141239, EXP. 9/30/2018; 3166728, EXP. 2/28/2019.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1175-2017
Classification
Class I
Status
Terminated
Recall initiated
Sep 5, 2017
FDA report date
Sep 27, 2017
Quantity
16,882
Recall type
Voluntary: Firm initiated
Recalling firm
Genentech, Inc.

Original FDA data

Every field from FDA enforcement report D-1175-2017, exactly as published.

Show all FDA fields
City
South San Francisco
State
CA
Status
Terminated
Country
United States
Event ID
78088
Address
1 Dna Way
Code information
Lot# 3128243, 3141239, EXP. 9/30/2018; 3166728, EXP. 2/28/2019.
Postal code
94080-4990
Report date
Sep 27, 2017
Product type
Drugs
Recall number
D-1175-2017
Classification
Class I
Recalling firm
Genentech, Inc.
Product quantity
16,882
Termination date
Jan 11, 2019
Reason for recall
Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 5, 2017
Initial firm notification
Letter
Center classification date
Dec 1, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1175-2017, published Sep 27, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls